Corrections to effect size variances for continuous outcomes of cross-over clinical trials by Kitchenham, BA et al.
Letter to the Editor
Statistics
in Medicine
Accepted draft: http://madeyski.e-informatyka.pl/download/KitchenhamMadeyskiCurtinSIM.pdf
(www.interscience.wiley.com) DOI: 10.1002/sim.7379
Corrections to effect size variances for
continuous outcomes of cross-over clinical trials
Barbara Kitchenham† and Lech Madeyski*‡ and François Curtin§
Keywords: cross-over trials; continuous data; effect sizes; effect size variances; corrections
1. Introduction
We would like to make some corrections to the formulas presented in the 2002 Statistics in Medicine article by Curtin et
al. [1]. That article presented formulas for the variances of standardized weighted mean difference of an AB/BA cross-over
trial that would be comparable both with parallel designs and cross-over designs.
There are three main issues in the Curtin et al.’s paper [1] that we address in this communication. Firstly, the paper
proposes a standardized effect size for cross-over trials that is inconsistent with the standardized effect sizes used for other
repeated measures designs such as the pretest-posttest studies used in educational studies, see [2] and [3]. Secondly, the
change to the standardized effect size for cross-over studies necessitates a change to variance of the standardized effect
size. Thirdly, the variance of the standardized effect size comparable with parallel trials was not based on the distribution
of a valid t-variable, so includes some errors. We follow Curtin et al.’s approach and base our revised variance equations
on the moments of the non-central t-distribution, replacing the t-variable with a variable based on the effect size.
2. The standardized effect sizes from AB/BA cross-over trials
Using Curtin et al.’s notation, the original paper derived the expectation and variance of the standardized mean difference
of the mean cross-over trial with a period effect from the equation:
d¯XO
sx
=
1
2 (d¯AB + d¯BA)
sx
(1)
d¯AB and d¯BA are the mean cross-over differences in sequences AB and BA respectively and s2x is the pooled within
sequence cross-over difference variance.
However, if we want a standardized effect size for cross-over designs that is consistent with other repeated measures,
the unstandardized effect size d¯XO should be standardized by the within-subject standard deviation, se [3]. se is also a
natural choice for the standardizer because s2e is the random effects residual term obtained when analysing cross-over data
with a linear mixed model. Since Curtin et al. note that s2x = 2s2e, it is easy to calculate
d¯XO
se
. For consistency with [3], we
refer to this standardized effect size as dRM , which is an estimate of the parameter δRM .
Curtin et al. correctly propose basing a standardized effect size comparable with parallel trials on the within- plus
between-subject variance, σ2b . For comparison with Morris and DeShon [3] we refer to this as dIG, where IG refers to
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independent groups, so:
dIG =
d¯XO
sb
(2)
while dIG estimates the parameter δIG. Curtin et al. point out that σ2b = σ
2
ξ + σ
2
e where σ2ξ is the between-subject variance.
Morris and DeShon [3] point out that dRM estimates the standardized expected change for individuals while dIG
estimates the standardized expected difference between the two methods. They note that either viewpoint might be the
objective of meta-analysis.
3. Standardized effect size variances
The variance estimate most suitable for small samples (up to ≈ 30 participants) for any standardized mean difference
effect size is derived from the non-central t distribution [3, 2]. Furthermore, Johnson and Welch [4] report the variance of
a t variable with mean θ to be:
V (θ) =
df
df − 2
(
1 + θ2
)− θ2
[c(df)]
2 (3)
Where θ is estimated by the sample t-value and df = (nAB + nBA − 2) is the degrees of freedom associated with the
t-test. Hedges [5] provides exact values of c(df) for values of df up to 50. In addition, Morris [2] confirmed that c(df) is
well-approximated by
(
1− 14df−1
)
even for small samples when estimating the variance of pretest-posttest standardized
effect sizes.
If we know the relationship between θ and a standardized effect size δ is given by the equation:
θ = A× δ (4)
where A is a constant term, then, the variance of δ is:
var(δ) =
1
A2
V (θ). (5)
This is true for any standardized effect size that can be calculated from a t-value, including those obtained from repeated
measures crossover designs, repeated measures pretest-posttest designs, and independent group designs.
In the case of a cross-over design, Senn [6] points out that the t test is based on:
t =
2d¯XO
sx
√(
1
nAB
+ 1nBA
) (6)
which suggests that sx is a natural standardizer of twice the effect size. Furthermore, since sx = se
√
2 and(
1
nAB
+ 1nBA
)
= (nAB+nBA)nABnBA
t = dRM
√
2nABnBA
(nAB + nBA)
(7)
Thus,
var(δRM ) = V (θ)
(nAB + nBA)
2nABnBA
(8)
Replacing θ by δRM
√
2nABnBA
(nAB+nBA)
and employing Equation 3:
var(δRM ) =
(
df
df − 2
)[
(nAB + nBA)
2nABnBA
+ δ2RM
]
− δ
2
RM
[c(df)]
2 (9)
This is similar to the equation for the variance of d¯XOsx given in the Appendix to [1]. The difference is only in the term
2nABnBA where Curtin et al. use the constant 4, and we use 2, because we standardize by se. However, for small sample
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sizes, it is inappropriate to replace δRM by dRM in Equation 9, because dRM is biased. For an unbiased estimate of δRM ,
we need to use the bias corrected estimate gRM = c(df)× dRM giving:
var(dRM ) =
(
df
df − 2
)[
(nAB + nBA)
2nABnBA
+ g2RM
]
− g
2
RM
[c(df)]
2 (10)
In addition, multiplying the variance of dRM by c(df)2, an unbiased estimate of the variance of gRM is:
var(gRM ) = c(df)
2
(
df
df − 2
)[
(nAB + nBA)
2nABnBA
+ g2RM
]
− g2RM (11)
To construct the variance of dIG it is necessary to consider the relationship between se and sb. This relies on the
correlation ρ between values obtained from the same subject:
ρ =
σ2ξ
σ2b
=
σ2b − σ2e
σ2b
(12)
so, se = sb
√
(1− ρˆ). Thus, based on Equation 1 and Equation 6, the relationship between t and dIG is:
t = dIG
√
2nABnBA
(1− ρˆ)(nAB + nBA) (13)
Therefore replacing δRM with δIG√
(1−ρˆ) in Equation 9 and multiplying by (1− ρˆ) gives:
var(δIG) =
(
df
df − 2
)[
(1− ρˆ)(nAB + nBA)
2nABnBA
+ δ2IG
]
− δ
2
IG
[c(df)]
2 (14)
Compared with the Equation 12 in [1], Equation 14 includes the term (1− ρˆ) in the first term on the right-hand side of
the equation and the term 2nABnBA rather than 4nABnBA. The inclusion of the term (1− ρˆ) in Equation 14 is comparable
with the equivalent equation for the variance of pretest-posttest standardized effect size [2].
However, again, if we want the most appropriate variance for small sample sizes, we should not replace δIG by dIG.
Like dRM , dIG is biased for small sample sizes, so we need to replace δIG with gIG = c(df)× dIG giving:
var(dIG) =
(
df
df − 2
)[
(1− ρˆ)(nAB + nBA)
2nABnBA
+ g2IG
]
− g
2
IG
[c(df)]2
(15)
In addition, the variance of gIG is:
var(gIG) = c(df)
2
(
df
df − 2
)[
(1− ρˆ)(nAB + nBA)
2nABnBA
+ g2IG
]
− g2IG (16)
4. Approximate standardized effect sizes for larger samples
For an approximate standardized effect size, Curtin et al. [1] use the formula proposed by [5] for var(dRM ). Since the
approximation assumes large sample sizes, the effect of the small sample size adjustment is negligible. So, after correcting
a typographical error in [1], the approximate variance for dRM is
var(dRM )Approx =
(nAB + nBA)
2nABnBA
+
d2RM
2(nAB + nBA − 3.94) (17)
In addition, based on the relationship between dRM and dIG, the large sample size approximation of the variance of dIG
is:
var(dIG)Approx = (1− ρˆ) (nAB + nBA)
2nABnBA
+
d2IG
2(nAB + nBA − 3.94) (18)
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